alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE>                      5
<CIK>                          0000718943
<NAME>                         DYCO OIL & GAS PROGRAM 1982-1 LIMITED PARTNERSHIP

<S>                            <C>
<PERIOD-TYPE>                  12-MOS
<FISCAL-YEAR-END>              DEC-31-1999
<PERIOD-START>                 JAN-01-1999
<PERIOD-END>                   DEC-31-1999
<CASH>                             23,930
<SECURITIES>                            0
<RECEIVABLES>                      33,560
<ALLOWANCES>                            0
<INVENTORY>                             0
<CURRENT-ASSETS>                   57,490
<PP&E>                         52,535,065
<DEPRECIATION>                 52,449,951
<TOTAL-ASSETS>                    208,291
<CURRENT-LIABILITIES>               4,562
<BONDS>                                 0
<PREFERRED-MANDATORY>                   0
<PREFERRED>                             0
<COMMON>                                0
<OTHER-SE>                        190,959
<TOTAL-LIABILITY-AND-EQUITY>      208,291
<SALES>                           171,172
<TOTAL-REVENUES>                  174,880
<CGS>                                   0
<TOTAL-COSTS>                     194,229
<OTHER-EXPENSES>                        0
<LOSS-PROVISION>                        0
<INTEREST-EXPENSE>                      0
<INCOME-PRETAX>                   (19,349)
<INCOME-TAX>                            0
<INCOME-CONTINUING>               (19,349)
<DISCONTINUED>                          0
<EXTRAORDINARY>                         0
<CHANGES>                               0
<NET-INCOME>                      (19,349)
<EPS-BASIC>                         (1.92)
<EPS-DILUTED>                           0



</TABLE>
<PAGE>   1
Coopers                                                               EXHIBIT 23
& Lybrand

                       CONSENT OF INDEPENDENT ACCOUNTANTS

                                      -----


We consent to the incorporation by reference in the registration statements of
Isomedix Inc. and Subsidiaries on Form S-3 (File Nos. 33-52474, 33-40342) and on
Form S-8 (File Nos. 2-87989, 2-87990, 33-41016, 33-48812, 33-73128) of our
report dated February 16, 1996 on our audits of the consolidated financial
statements and financial statement schedules of Isomedix Inc. and Subsidiaries
as of December 31, 1995 and 1994 and for the years ended December 31, 1995, 1994
and 1993, which report is included in this Annual Report on Form 10-K.


Parsippany, New Jersey
March 29, 1996

                                                    /s/ Coopers & Lybrand L.L.P.
================================================================================


Exhibit 23.1



              CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS


As  independent  registered  public  accountants,   we  hereby  consent  to  the
incorporation  by reference  in the  Registration  Statements  on Form S-8 (Nos.
033-53524,  as amended, and 333-69057) and in the related  Prospectuses,  of our
report dated September 28, 2007 related to the consolidated financial statements
of  Dynatronics  Corporation  included in its Form  10-KSB for the fiscal  years
ended June 30, 2007 and 2006.





/s/ Tanner LC


Salt Lake City, Utah
September 28, 2007
|Skip to ContentRelease Date: September 16, 2004Release dates | 
 Coded tables | 
 Historical dataCurrent release | 
 Screen reader | 
 PDF (450 KB)
F.227 Investment in Bank Personal Trusts and Estates
   Billions of dollars; quarterly figures are seasonally adjusted annual rates                                                                                                                                            
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Description
1999
2000
2001
2002
2003
2003   Q1
2003   Q2
2003   Q3
2003   Q4
2004   Q1
2004   Q2
LineBank personal trusts and estates total financial liabilities liability
	-8.1
	56.6
	-59.9
	-2.4
	-26.3
	-26.6
	-26.4
	-26.4
	-25.5
	29.8
	8.2
	1Bank personal trusts and estates total financial liabilities liability
	-8.1
	56.6
	-59.9
	-2.4
	-26.3
	-26.6
	-26.4
	-26.4
	-25.5
	29.8
	8.2
	2
|
|Bank personal trusts and estates total financial liabilities liability                                                                                                                                                                                                                                                                                                                                                                   
|Bank personal trusts and estates total financial liabilities liability                                                                                                                                                                                                                                                                                                                                                                   
|Release dates | 
Coded tables | 
Historical dataCurrent release | 
Screen reader | 
PDF (450 KB)

Statistical releasesHome | Economic research and
dataAccessibility | Contact Us Last update: September 16, 2004
EXHIBIT 32.1
                                                                    ------------




CHIEF EXECUTIVE OFFICER'S CERTIFICATION TO U.S.C. SECTION 1350 AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the accompanying Form 10-QSB of ZAP for the nine months ended
September 30, 2004, Steven M. Schneider, Director and Chief Executive Officer of
ZAP, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

(1)  such Form 10-QSB of ZAP for the nine months ended September 30, 2004, fully
     complies with the requirements of Section 13 (a) or 15 (d) of the
     Securities Exchange of 1934; and

(2)  the information contained in such Form 10-QSB of ZAP for the nine months
     ended September 30, 2004,fairly presents, in all material respects, the
     financial condition and results of operations of ZAP .







/s/  Steve  Schneider
-------------------------------
Steve  Schneider
Director and Chief Executive Officer


November 12, 2004
<PAGE>
 
                                                                   EXHIBIT 11.1

                           MASTECH CORPORATION
                   CALCULATION OF  PER SHARE EARNINGS
                    --------------------------------------
              (Dollars in thousands, except per share data)
                 ---------------------------------------------
                               (Unaudited)
                               -----------
<TABLE>
<CAPTION>
                                                                    For the Quarter Ended
                                                               -------------------------------
                                                               March 31, 1997  March 31, 1996
                                                               --------------  ---------------
<S>                                                            <C>             <C>
                                                                                   (Pro Forma
                                                                                  Information)
                                               
Weighted average common shares............................         21,654,600      18,200,000
                                               
Dilutive effect of stock issued within one year of the  
 initial public offering..................................                ---          54,600
                                               
                                               
Dilutive effect of common stock equivalents...............             80,596             ---
                                               
                                               
Total weighted average shares.............................         21,735,196      18,254,600
                                                                  ===========     ===========
                                               
Net income and pro forma net income, respectively                 $     2,309     $     2,059
                                                                  ===========     ===========
Net income and pro forma net income per share of
 common stock, respectively                                       $      0.11     $      0.11 
                                                                  ===========     ===========
</TABLE>
**Exhibit 31.2**

 

**Chief Financial Officer Certification**

 

I, Wendy A. Nieto certify that:

 

(1)  I have reviewedthis report on Form 10-Q of Intraware, Inc. (the “registrant”);

 

(2)  Based on myknowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

 

(3)  Based on myknowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report;

 

(4)  The registrant’sother certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as is defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:

 

(i)  Designed such disclosure controls and procedures, or causedsuch disclosure controls and procedures to be designed under our supervision,to ensure that material information relating to the registrant, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this report is being prepared;

 

(ii)  Evaluated the effectiveness of the registrant’s disclosurecontrols and procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures as of the end of theperiod covered by this report based on such evaluation; and

 

(iii)  Disclosed in this report any change in the registrant’sinternal control over financial reporting that occurred during the registrant’smost recent fiscal quarter (the registrant’s fourth fiscal quarter in the caseof an annual report) that has materially affected, or is reasonably likely tomaterially affect, the registrant’s internal control over financial reporting;and

 

(5)  The registrant’sother certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of the registrant’s board of directors (orpersons performing the equivalent functions):

 

(i)  All significant deficiencies and material weaknesses in thedesign or operation of internal control over financial reporting which arereasonably likely to adversely affect the registrant’s ability to record,process, summarize and report financial information; and

 

(ii)  Any fraud, whether or not material, that involves managementor other employees who have a significant role in the registrant’s internalcontrol over financial reporting.

 

Dated:                July 14, 2006

 
| /s/   WENDY A. NIETO           |   |
|------------------------------------------|--------|
| Wendy A. Nieto                      |
| *Chief Financial Officer and Executive*  |
| *Vice President of Intraware, Inc.* |
| *(Principal Financial Officer)*          |

 

----
IN THE UNITED STATES DISTRICT COURT

FOR THE DISTRICT OF COLORADO

Civil Action No. 11-cv-02568-CMA-BNB

THE WELLINGER FAMILY TRUST 1998;

JULIE WELLINGER, trustee, and

JULIE WELLINGER, individually,

Plaintiffs,

v.

HARTFORD LIFE AND ACCIDENT INSURANCE COMPANY, a Connecticut insurance

company,

Defendant.

______________________________________________________________________________

MINUTE ORDER

______________________________________________________________________________

Minute Order Entered by Magistrate Judge Boyd N. Boland

This matter is before the Court on the Stipulated Motion to Amend the Scheduling

Order [docket no. 37, filed August 6, 2012] (the “Motion”).

IT IS ORDERED that the Motion is GRANTED and the discovery cut-off is extended to

and including November 30, 2012, and the dispositive motion deadline is extended to and

including December 31, 2012.

IT IS FURTHER ORDERED that the Pretrial Conference set for October 30, 2012, is

vacated and reset to March 14, 2013, at 9:30 a.m., in Courtroom A-401, Fourth Floor, Alfred

A. Arraj United States Courthouse, 901 19th Street, Denver, Colorado 80294. The proposed

Pretrial Order, submitted pursuant to District of Colorado ECF Procedures V.5.1, is due on or

before March 7, 2013. Please remember that anyone seeking entry into the Alfred A. Arraj

United States Courthouse will be required to show a valid photo identification. See

D.C.COLO.LCivR 83.2B.

DATED: August 7, 2012

Case 1:11-cv-02568-CMA-BNB Document 39 Filed 08/07/12 USDC Colorado Page 1 of 1
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S FINANCIAL STATEMENT INCLUDED IN THIS QUARTERLY REPORT ON FORM 10-Q AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         148,000
<SECURITIES>                                         0
<RECEIVABLES>                                2,934,000
<ALLOWANCES>                                 1,239,000
<INVENTORY>                                  1,480,000
<CURRENT-ASSETS>                             3,692,000
<PP&E>                                       2,249,000
<DEPRECIATION>                                 339,000
<TOTAL-ASSETS>                              20,229,000
<CURRENT-LIABILITIES>                       13,762,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       109,000
<OTHER-SE>                                   6,037,000
<TOTAL-LIABILITY-AND-EQUITY>                20,229,000
<SALES>                                     16,444,000
<TOTAL-REVENUES>                            16,444,000
<CGS>                                       14,969,000
<TOTAL-COSTS>                               23,130,000
<OTHER-EXPENSES>                             (364,000)
<LOSS-PROVISION>                           (6,322,000)
<INTEREST-EXPENSE>                           1,835,000
<INCOME-PRETAX>                            (8,157,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (8,157,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                              (105,000)
<CHANGES>                                            0
<NET-INCOME>                               (8,262,000)
<EPS-BASIC>                                     (0.76)
<EPS-DILUTED>                                   (0.76)


</TABLE>
Exhibit 32.2



CERTIFICATION PURSUANT TO



18 U.S.C. SECTION 1350,



AS ADOPTED PURSUANT TO



SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of World Health Alternatives, Inc. (the Company) on Form 10-KSB for the year ending December 31, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, Richard E. McDonald, Principal Financial Officer and Principal Accounting Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to
§ 906 of the Sarbanes-Oxley Act of 2002, that:



(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and



(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



|                                  
|----------------------------------
|/s/ Richard E. McDonald           
|Richard E. McDonald               
|Principal Financial Officer,      
|Principal Accounting Officer,     
|Chairman of the Board of Directors



May 13, 2005
Exhibit 32.2



CERTIFICATION PURSUANT TO



18 U.S.C. SECTION 1350,



AS ADOPTED PURSUANT TO



SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of World Health Alternatives, Inc. (the Company) on Form 10-KSB for the year ending December 31, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, Marc D. Roup, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002,
that:



(1) The Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and



(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.



|    |  |                                      
|--- |  | -------------------------------------
|By: |  | /s/ Marc D. Roup                     
|    |  | Marc D. Roup, Chief Executive Officer
|    |  |                                      



Dated: April 28, 2004
[Federal Register Volume 73, Number 195 (Tuesday, October 7, 2008)]
[Notices]
[Pages 58668-58669]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-23705]


=======================================================================
-----------------------------------------------------------------------

NATIONAL FOUNDATION FOR THE ARTS AND THE HUMANITIES


National Endowment for the Arts; National Council on the Arts 
165th Meeting

    Pursuant to section 10 (a) (2) of the Federal Advisory Committee 
Act (Pub. L. 92-463), as amended, notice is hereby given that a meeting 
of the National Council on the Arts will be held on October 31, 2008 in 
Room M-09 at the Nancy Hanks Center, 1100 Pennsylvania Avenue, NW., 
Washington, DC 20506.

[[Page 58669]]

    This meeting, from 9 a.m. to 11:30 a.m. (ending time is 
approximate), will be open to the public on a space available basis. 
The meeting will begin with opening remarks and will include a poetry 
reading by David Lehman, a performance from Shakespeare by Aquila 
Theater Company, and a jazz performance by pianist Helen Sung. After 
the presentations the Council will review and vote on applications and 
guidelines, and the meeting will end with remarks and Council members' 
farewell to the Chairman.
    If, in the course of the open session discussion, it becomes 
necessary for the Council to discuss non-public commercial or financial 
information of intrinsic value, the Council will go into closed session 
pursuant to subsection (c)(4) of the Government in the Sunshine Act, 5 
U.S.C. 552b. Additionally, discussion concerning purely personal 
information about individuals, submitted with grant applications, such 
as personal biographical and salary data or medical information, may be 
conducted by the Council in closed session in accordance with 
subsection (c) (6) of 5 U.S.C. 552b.
    Any interested persons may attend, as observers, Council 
discussions and reviews that are open to the public. If you need 
special accommodations due to a disability, please contact the Office 
of AccessAbility, National Endowment for the Arts, 1100 Pennsylvania 
Avenue, NW., Washington, DC 20506, 202/682-5532, TTY-TDD 202/682-5429, 
at least seven (7) days prior to the meeting.
    Further information with reference to this meeting can be obtained 
from the Office of Communications, National Endowment for the Arts, 
Washington, DC 20506, at 202/682-5570.

    Dated: October 2, 2008.
Kathy Plowitz-Worden,
Panel Coordinator, Office of Guidelines and Panel Operations.
 [FR Doc. E8-23705 Filed 10-6-08; 8:45 am]
BILLING CODE 7537-01-P
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

AARON JOSEPH CUNNINGHAM, 

Petitioner-Appellant, 

 v. 

UNITED STATES OF AMERICA, 

Respondent-Appellee.

No. 23-35262 

D.C. No. 4:22-cv-05165-MKD 

MEMORANDUM*

Appeal from the United States District Court

for the Eastern District of Washington

Mary K. Dimke, District Judge, Presiding

Submitted September 12, 2023**

Before: CANBY, CALLAHAN, and OWENS, Circuit Judges.

Federal pretrial detainee Aaron Joseph Cunningham appeals from the district 

court’s judgment dismissing his 28 U.S.C. § 2241 habeas corpus petition 

challenging his pretrial detention and seeking $ 100,000,000 in gold bullion. We 

have jurisdiction under 28 U.S.C. § 1291. We review de novo, see McNeely v. 

* This disposition is not appropriate for publication and is not precedent 

except as provided by Ninth Circuit Rule 36-3.

** The panel unanimously concludes this case is suitable for decision 

without oral argument. See Fed. R. App. P. 34(a)(2). 

FILED

SEP 22 2023

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 23-35262 

Blanas, 336 F.3d 822, 826 (9th Cir. 2003) and we affirm.

Cunningham’s claim that pretrial detention categorically violates 

defendants’ due process rights fails. See United States v. Salerno, 481 U.S. 739, 

742, 751-55 (1987). Even assuming Cunningham can assert individualized 

challenges to his pretrial detention in a § 2241 petition—an issue we need not and 

do not decide—he has not shown any constitutional violations here.1

This disposition is without prejudice to any motion Cunningham’s counsel 

may wish to file in his ongoing criminal proceedings in the district court 

challenging his pretrial detention. 

We do not consider Cunningham’s remaining arguments, which he raised for 

the first time on appeal. See Padgett v. Wright, 587 F.3d 983, 985 n.2 (9th Cir. 

2009). 

All pending motions are denied. 

AFFIRMED. 

1 Even if Cunningham could establish that his pretrial detention violated his 

constitutional rights, he cannot seek damages on that basis. See Nelson v. 

Campbell, 541 U.S. 637, 646 (2004) (“damages are not an available habeas 

remedy”).